Correlation Engine 2.0
Clear Search sequence regions

  • Akt (1)
  • Akt1 (1)
  • CBL (1)
  • cell movement (1)
  • children (1)
  • female (1)
  • flow (1)
  • genes (2)
  • GM- CSF (5)
  • leukemia (7)
  • macrophages (3)
  • MAPK (1)
  • marrow (1)
  • mice (6)
  • monocytes (3)
  • MPN (3)
  • Neurofibromin 1 (2)
  • Nf1 (3)
  • nf1 genes (1)
  • pathogenesis (1)
  • patients (1)
  • protein b (1)
  • Pten (3)
  • pten protein (3)
  • PTPN11 (1)
  • RAS (1)
  • ras proteins (2)
  • stem cells (1)
  • tensin (1)
  • time factors (1)
  • Sizes of these terms reflect their relevance to your search.

    Juvenile myelomonocytic leukemia (JMML) is an aggressive pediatric mixed myelodysplastic/myeloproliferative neoplasm (MDS/MPN). JMML leukemogenesis is linked to a hyperactivated RAS pathway, with driver mutations in the KRAS, NRAS, NF1, PTPN11, or CBL genes. Previous murine models demonstrated how those genes contributed to the selective hypersensitivity of JMML cells to granulocyte macrophage-colony-stimulating factor (GM-CSF), a unifying characteristic in the disease. However, it is unclear what causes the early death in children with JMML, because transformation to acute leukemia is rare. Here, we demonstrate that loss of Pten (phosphatase and tensin homolog) protein at postnatal day 8 in mice harboring Nf1 haploinsufficiency results in an aggressive MPN with death at a murine prepubertal age of 20 to 35 days (equivalent to an early juvenile age in JMML patients). The death in the mice was due to organ infiltration with monocytes/macrophages. There were elevated activities of protein kinase B (Akt) and mitogen-activated protein kinase (MAPK) in cells at physiological concentrations of GM-CSF. These were more pronounced in mice with Nf1 haploinsufficiency than in littermates with wild-type Nf1,but this model is insufficient to cause cells to be GM-CSF hypersensitive. This new model represents a murine MPN model with features of a pediatric unclassifiable mixed MDS/MPN and mimics many clinical manifestations of JMML in terms of age of onset, aggressiveness, and organ infiltration with monocytes/macrophages. Our data suggest that the timing of the loss of PTEN protein plays a critical role in determining the disease severity in myeloid malignancies. This model may be useful for studying the pathogenesis of pediatric diseases with alterations in the Ras pathway. © 2016 by The American Society of Hematology.


    Y Lucy Liu, Yan Yan, Cody Webster, Lijian Shao, Shelly Y Lensing, Hongyu Ni, Wei Feng, Natalia Colorado, Rupak Pathak, Zhifu Xiang, Martin Hauer-Jensen, Shaoguang Li, Daohong Zhou, Peter D Emanuel. Timing of the loss of Pten protein determines disease severity in a mouse model of myeloid malignancy. Blood. 2016 Apr 14;127(15):1912-22

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 26764354

    View Full Text